Contact

About us
Strategies
- Human Health
- Planetary Health
  - BioEconomy
Portfolio
Team
Sustainability
- Human Health
- Planetary Health
News & Insights
- News
- Insights
- Events
- Media resources

Contact

Linkedin YouTube X

About us

Impacting the future
History
Careers

Strategies

Human Health
Planetary Health

Portfolio

Ventures
Growth
BioEconomy

Team

Sustainability

Human Health
Planetary Health

News & Insights

News
Insights
Events
Media resources

News & Insights

Amsterdam Molecular Therapeutics Amends Amgen GDNF Gene License Agreement

News

Amsterdam Molecular Therapeutics Amends Amgen GDNF Gene License Agreement

March 12, 2010

Human Health

Portfolio

Back

Share

Download

Newsletter

Subscribe to our news releases

Location

NL

Gooimeer 2-35

1411 DC Naarden

31 35 699 30 00

DE

Sternstrasse 21 

80538 Munich

US

200 Clarendon Street
22nd Floor 

Boston, MA 02116

Company

News & Insights

Social

Privacy policy Terms & conditions Cookie policy Grievances

Made with Friend Studio

© 2025 Forbion

Terms & conditions

Made with Friend Studio

© 2025 Forbion

Subscribe

Yes, I give permission to store and process my data